quantisnow
FeedTopReportsPricing
⌘K
Live feed
19:49:04·1830d
INSIDERFiling
Five Prime Therapeutics, Inc. logo

SEC Form 4: White David disposed of $1,270,074 worth of Common Stock back to the company (33,423 units at $38.00) , decreasing direct ownership by 100% to 0 units (tax withholding)

FPRX· Five Prime Therapeutics, Inc.
Health Care
Original source

Companies

  • FPRX
    Five Prime Therapeutics, Inc.
    Health Care

Related

  • PR1571d
    Apexigen Announces Appointment of Francis Sarena as Chief Operating Officer
  • SEC1802d
    SEC Form SC 13G/A filed by Five Prime Therapeutics, Inc. (Amendment)
  • SEC1823d
    SEC Form 15-12B filed by Five Prime Therapeutics, Inc.
  • SEC1828d
    SEC Form EFFECT filed by Five Prime Therapeutics, Inc.
  • INSIDER1830d
    SEC Form 4: Sarena Francis Willard received a gift of 2,385 units of Common Stock, was granted 66,000 units of Common Stock, disposed of $6,530,414 worth of Common Stock back to the company (171,853 units at $38.00) and gifted 20,459 units of Common Stock, decreasing direct ownership by 100% to 0 units to satisfy withholding obligation
  • INSIDER1830d
    SEC Form 4: Smith David V was granted 66,000 units of Common Stock and disposed of $5,279,986 worth of Common Stock back to the company (138,947 units at $38.00) , decreasing direct ownership by 100% to 0 units to satisfy tax liability
  • INSIDER1830d
    SEC Form 4: Collins Helen Louise disposed of $5,150,786 worth of Common Stock back to the company (135,547 units at $38.00) , gifted 8,085 units of Common Stock and was granted 66,000 units of Common Stock, decreasing direct ownership by 100% to 0 units to satisfy tax liability
  • INSIDER1830d
    SEC Form 4: RINGO WILLIAM R gifted 10,000 units of Common Stock, decreasing direct ownership by 100% to 0 units
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022